Category: Clinical

Post

FHC and NeuraLynx Exhibiting at AES

FHC, Inc. and NeuraLynx (an FHC Company), will be exhibiting at AES’s Annual Meeting December 1st through the 5th at the…

Post

New NeuraLynx Website Launch

After the acquisition of Neuralynx into FHC’s family of brands, we are launching a new Neuralynx website! This rebuilt web…

Post

FHC Exhibiting at ESSFN

FHC, Inc. will be exhibiting at the 25th Congress of the European Society for Stereotactic and Functional Neurosurgery in Stockholm,…

Post

New Guideline 5 Software Update

  The Guideline 5 software update to version 2.2.0 includes minor enhancements and bug fixesincluding the following:  Power Spectral Density…

Post

FHC Launches New STarFix Direct Website

FHC is excited to announce the launch of our new STarFix Direct website, offering a new robust and user-friendly way…

Post

FHC Announces FDA Clearance for Guideline 5 System

BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food…

Post

FHC products enable use of new surgical technique for Parkinson’s sufferers in Australia

Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients affected…

Popup Image